Wilkinson Stekloff Partners Kieran Gostin, Rakesh Kilaru, and Moira Penza were named to the 2022 Benchmark Litigation 40 & Under List, the guide to the nation’s most notable up-and-coming litigation attorneys. This is the second consecutive year that all three partners have been recognized by Benchmark, with Kieran making a third appearance and Rakesh securing a spot each year since 2018. Kieran has made his career representing the government and private clients in high-profile matters. Recently, he has represented clients in several major class actions, including obtaining a complete defense verdict in a rare trial of a major consumer class action. Over the past five years, he has also gone to trial in five product-liability trials, securing defense judgments in each case. Rakesh specializes in delivering favorable results to clients at every stage of litigation, tackling everything from arguing dispositive motions to crossing expert witnesses at trial to arguing precedent-setting appeals. He …
2021 Year In Review
January 26, 2022
WASHINGTON — In 2021, despite ongoing pandemic-related delays and challenges, the Wilkinson Stekloff team continued to litigate with the intensity and success that has cemented our reputation as the leading trial boutique in the country. In a year where trials remained scarce, WS tried two high-profile cases in 2021: WS served as lead trial counsel for Altria Group, Inc. in an adversarial administrative proceeding before the FTC. The FTC alleged that Altria and JLI violated antitrust laws through Altria’s purchase of a minority interest in JLI. At trial, Founding Partner Beth Wilkinson handled opening statements and examined multiple high-profile witnesses, including Altria’s current and former CEO, Altria’s general counsel, and both sides’ economic experts. WS Partner Moira Penza examined Altria’s scientists, and WS Partner James Rosenthal played a central role in strategy and legal briefing. After a single day of deliberation in October 2021, a jury delivered the first-ever verdict for Monsanto in litigation over whether the herbicide Roundup causes …
Wilkinson Stekloff Wins First-Ever Jury Verdict for Monsanto in Roundup Mass Tort Litigation
October 6, 2021
After a single day of deliberation, a jury delivered the first-ever verdict for Monsanto yesterday in Clark v. Monsanto, a trial involving claims that the herbicide Roundup causes Non-Hodgkin Lymphoma. Wilkinson Stekloff Founding Partner Brian Stekloff first-chaired the trial; Associate Cali Cope-Kasten handled several witnesses, and Partner Kieran Gostin advised on all aspects of trial strategy. Clark was the fourth case in this mass tort to go to trial; the three previous trials resulted in verdicts against Monsanto ranging from $81 million to over $2 billion. Clark was also the first case involving a child plaintiff. The victory was the product of a comprehensive trial strategy. Shortly after being retained as lead trial counsel, Brian convinced the judge to “reverse bifurcate” the case into a first phase focused on causation and a second phase focused on liability and damages. The ruling marked the first time a state court judge has …
Wilkinson Stekloff Partner Kieran Gostin Featured in Law.com’s “How I Made Partner” Series
August 16, 2021
For its series asking top-tier lawyers about their rise, and the advice they would offer up-and-coming lawyers, Law.com recently featured Wilkinson Stekloff partner Kieran Gostin. Kieran on the biggest surprise about becoming a partner: “…I came to realize that, in many ways, making partner is just the start of your career, and definitely not the culminating event that it can seem like when you are just starting out.” Kieran’s advice to young associates who want to make partner: “We are in a client-service business, and it is never too early to really start putting yourself in that mindset every day and focusing on how you can help your clients succeed. COVID-19 has not changed that advice.” Kieran was also recently featured on Benchmark Litigation’s 40 & Under Hot List for the second year in a row, and was named a 2020 National Law Journal D.C. Rising Star. He was recently part …
Wilkinson Stekloff Partners Kieran Gostin, Rakesh Kilaru, and Moira Penza named to Benchmark Litigation’s 2021 40 & Under Hot List
July 21, 2021
WASHINGTON, D.C. — Benchmark Litigation has honored three Wilkinson Stekloff partners on its exclusive “40 & Under Hot List” of the most notable up-and-coming litigators in the U.S. Kieran Gostin, Rakesh Kilaru, and Moira Penza were noted as being among the best and brightest young law firm partners in the country, based on Benchmark research taking into account their work on noteworthy recent cases and input from clients and peers. Benchmark is hailed as the Definitive Guide to America’s Leading Litigation Firms and Attorneys. “We are proud to see our partners recognized for their hard work and dedication to achieving great results for our clients,” said Founding Partner Beth Wilkinson. “As a firm, we’re committed to developing the next generation of trial lawyers. Kieran, Rakesh, and Moira exemplify that emerging leadership and are outstanding role models within the firm.” Kieran has been included on the list for the second year in …
Wilkinson Stekloff Partner Kieran Gostin Named National Law Journal D.C. Rising Star
August 5, 2020
WASHINGTON – Wilkinson Stekloff Partner Kieran Gostin was named a 2020 National Law Journal D.C. Rising Star. One of 40 honorees, Kieran was recognized for his role on a trial team that won a defense victory for Bayer in a $600 million certified consumer class action lawsuit and his role in the Farar case, where he successfully cross-examined Plaintiffs’ Florida class representative, one of the four witnesses that testified at trial. The award honors attorneys ranging from a variety of practice areas—from appellate to First Amendment to international trade—representing high-profile clients and securing victories. In a Q&A with the National Law Journal, Kieran outlined his biggest accomplishments, most valuable lesson learned, mentorship, and the key to his success. His responses can be found here and below. Describe your biggest win or accomplishment in practice. A defense verdict in a consumer class action about multivitamin advertising. Our client knew it was …
Wilkinson Stekloff Partners Rakesh Kilaru and Kieran Gostin Named to Benchmark Litigation “40 & Under Hot List”
July 30, 2020
WASHINGTON – Wilkinson Stekloff Partners Rakesh Kilaru and Kieran Gostin were named to the 2020 Benchmark Litigation “40 & Under Hot List.” Benchmark recognized them as leading and notable up-and-coming litigation partners in the United States. This marks the third consecutive year Rakesh has been recognized by Benchmark. Founding Partner Beth Wilkinson said, “Rakesh and Kieran continue to demonstrate what it means to be stellar attorneys and exemplary role models. I am proud to see their hard work and dedication to achieving the greatest result for their clients in the courtroom being honored and recognized. We are thrilled to have them as part of our team and look forward to their future accomplishments.” Benchmark recognized Rakesh for his involvement in a “wide range of antitrust, sports, product liability, commercial, class action, and appellate litigation,” including high-profile antitrust cases for the national Collegiate Athletic Association (NCAA) and the National Football League …
National Law Journal Recognizes Wilkinson Stekloff’s Industry-Leading Products Liability/Mass Tort Trial Practice
May 28, 2020
WASHINGTON – The National Law Journal selected Wilkinson Stekloff as one of its Washington D.C. Litigation Departments of the Year in Products Liability/Mass Torts. NLJ’s selection was based on Wilkinson Stekloff’s string of trial victories in high-profile products liability cases. Most recently, the firm, led by Alex Walsh, Kieran Gostin, and James Rosenthal, won a decisive victory in Bayer v. Farar, a certified consumer class action trial involving $600 million in claimed damages. Previously, the firm reeled off five straight victories in the Xarelto products liability litigation, with Beth Wilkinson, Alex Walsh, Brian Stekloff, Jeremy Barber, Tamarra Matthews Johnson, and Rakesh Kilaru serving in lead roles. NLJ’s profile on the firm highlights commentary from Beth, Alex, and Brian on their strategy and approach to litigation. “We believe that at the heart of every case is a simple compelling narrative, a narrative that shows the jury why our side should prevail,” …
Wilkinson Stekloff Celebrates Another Outstanding Year of High Stakes Trials and Accolades for the Next Generation of Trial Lawyers
December 30, 2019
WASHINGTON –Wilkinson Stekloff enters its fifth year having cemented its status as the premier trial litigation boutique in the country. 2019 featured three high-stakes, high-pressure trials, in which different partners served as lead trial counsel and eight partners in total had stand-up roles. The firm continued to receive accolades for its successes in delivering results to its clients while deepening its diverse bench of go-to litigators.
Wilkinson Stekloff Announces Three Promotions
June 6, 2019
WASHINGTON — Wilkinson Stekloff today announced three promotions. Kieran Gostin and Ralia Polechronis were elected to the partnership, and Andrew Croner was promoted to counsel. The promotions took effect on June 1. “Kieran, Ralia, and Andrew have each in their own ways played an integral role in many of the firm’s successes, from inside the courtroom to mentoring fellow colleagues,” said founding partner Alex Walsh. “We are truly fortunate to have them in the Wilkinson Stekloff family. Their well-deserved promotions are a testament to their value to the firm.” An experienced defense attorney, Kieran has represented government and corporate clients in products liability, antitrust, data breach, copyright, national security, First Amendment, Privacy Act, Administrative Procedure Act, and other complex civil litigation matters. Kieran recently helped lead a trial team that won a decisive victory for Bayer in a $600 million certified consumer class action lawsuit (Farar et al. v. Bayer) …